SBC Medical Group Holdings Inco
3.3800-0.28 (-7.65%)
Oct 29, 4:00:00 PM EDT · NasdaqGM · SBC · USD
Key Stats
Market Cap
346.71MP/E (TTM)
10.56Basic EPS (TTM)
0.32Dividend Yield
0%Recent Filings
8-K
Q2 revenues drop 18% to $43M
SBC Medical Group Holdings reported Q2 2025 revenues of $43 million, down 18% year-over-year, hit by staffing business discontinuation, divestitures, and fee revisions—yet franchise locations swelled to 259, up 36, while customer visits hit 6.31 million, up 14%. Net income plunged 87% to $2.5 million, with EBITDA at $15 million and a 35% margin, reflecting strategic pivots amid Japan's cautious spending. Operations remain robust. Forward-looking confidence centers on franchise optimization and higher-margin shifts.
10-Q
Q2 FY2025 results
SBC Medical Group Holdings posted Q2 FY2025 revenue of $43.4M, down 18% y/y but up 10% q/q (derived), as fee revisions for franchising and management services trimmed topline gains, while rental and procurement streams grew on new clinic demand and equipment upgrades. Gross margins held at 69%, with operating income at $14.6M versus $27.3M y/y, pressured by higher consulting fees tied to Nasdaq listing. Diluted EPS of $0.02 aligns with 103.5M shares, reflecting a $9.7M deemed contribution from aircraft sale adjustment boosting equity. Cash swelled to $152.7M, up 22% q/q, with $7.1M low-rate debt and ample revolver headroom; free cash flow not disclosed in the 10-Q. Yet competition from rival aesthetics chains could squeeze margins further.
8-K
SBC acquires Japanese clinic network
SBC Medical Group Holdings acquired MB Career Lounge on July 17, 2025, via a cash share purchase funded by a bank loan, bringing JUN CLINIC's network into its portfolio. This move diversifies services across aesthetic dermatology and plastic surgery in Japan, tapping into a ¥631 billion market that grew 6.2% last year. Acquisition bolsters revenue stability. Yet integration risks loom amid market uncertainties.
8-K
SBC joins Russell 3000
SBC Medical Group Holdings joined the Russell 3000 Index on June 30, 2025, as part of the annual reconstitution, gaining automatic entry into the Russell 1000 or 2000 based on market cap. This boosts visibility for the aesthetic clinic franchisor, drawing institutional investors who track $10.6 trillion in assets against Russell benchmarks. Inclusion lasts one year. Yet risks like market volatility persist.
8-K
Board declassification approved
SBC Medical Group Holdings stockholders approved an amended and restated certificate of incorporation at the June 13, 2025 annual meeting, declassifying the board so all directors' terms end in 2026, with annual elections thereafter. The proposal passed overwhelmingly with 92,710,188 for and just 251 against, while also ratifying MaloneBailey as auditors. This shift boosts accountability. Yet, it exposes the board to yearly scrutiny.
AIRS
AirSculpt Technologies, Inc.
10.90-0.67
BMGL
Basel Medical Group Ltd
1.53-0.05
DFCO
Dalrada Financial Corp.
0.04+0.01
EGG
Enigmatig Limited
4.75+0.42
HCSG
Healthcare Services Group, Inc.
18.81-0.42
HURN
Huron Consulting Group Inc.
169.61+17.13
PAIYY
Aesthetic Medical International
0.13-0.08
RMTG
Regenerative Medical Technology
0.05+0.00
SSHT
SSHT S&T Group Ltd.
0.14+0.01
YJGJ
Yijia Group Corp.
1.61+0.00